Schering-Plough Announces FDA Approval of Saphris (asenapine)

Links shared publicly online about this topic.

  • 1,822
    total visits

Schering-Plough Announces FDA Approval of Saphris (asenapine)

drugs.com

Saphris (asenapine) is used to treat schizophrenia and bipolar I disorder. Includes Saphris side effects, interactions and indications.

View full resource at drugs.com

Tags: Schizophrenia, Psychotic Disorder, Disease and Condition, FDA

  • Share

Most Recently Shared on August 15, 2009 at 6:07 am By:

drugscom Drugs.com

Schering-Plough Announces FDA Approval of Saphris (asenapine) - http://bit.ly/XvAmd

3 years ago...

Saphris: It's Different without Actually Being Different | Psydir News

news.psydir.com — “On August 14th, the FDA approved Schering-Plough's second generation antipsychotic drug Saphris (asenapine) for the acute treatment of schizophrenia, and the acute treatment of mania/mixed episodes associated with bipolar I disorder (1). Question: Should I, at all be concerned that there are more actual published peer-reviewed articles of this drug being tested in rats (2, 3, 4, 5, 6 ) than in hum...View full resource at news.psydir.com

  • View Related
  • Share

Most Recently Shared on September 4, 2009 at 11:34 am By:

psydir PsyDir News Health News

Saphris: It's Different without Actually Being Different http://ow.ly/15NICd

3 years ago...

FDA OKs Schering-Plough Drug for Schizophrenia, Bipolar - WSJ.com

online.wsj.com — “The FDA gave final approval to Schering-Plough's Saphris, a treatment for both schizophrenia and bipolar disorder in adults.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on August 19, 2009 at 7:15 pm By:

medpedia The Medpedia Project Health Site

FDA Approves Asenapine for Schizophrenia, Bipolar Disorder: http://bit.ly/4uyHBi

3 years ago...

Saphris approved for schizophrenia and bipolar I disorder - MPR

empr.com — “The FDA has approved Saphris (asenapine sublingual tablets, from Schering-Plough), a psychotropic agent, for the acute treatment of schizophrenia in adults and the acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 14, 2009 at 3:41 pm By:

eMPR MPR Medical Publisher

MPR News: Saphris approved for schizophrenia and bipolar I disorder: The FDA has approved Saphris (asen.. http://bit.ly/A4RkP

3 years ago...

Advertisement